4D Molecular Therapeutics
$14.97
44
+$0.27+1.84% Friday 20:00
-$0.29-1.94%Friday 23:30After hours
Statistics
Day High
14.96
Day Low
14.94
52W High
16.93
52W Low
6.47
Volume
10,297
Avg. Volume
-
Mkt Cap
827.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.05
-0.94
-0.83
-0.73
Expected EPS
-1.047778
Actual EPS
N/A
Financials
-164.43%Profit Margin
Unprofitable85.21MRevenue
-140.11MNet Income
Analyst Ratings
31.00Average Price Target
The highest estimate is 37.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow FDMT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
Pfizer
PFE
Mkt Cap159.36B
Solid Biosciences
SLDB
Mkt Cap1.05B
Intellia Therapeutics
NTLA
Mkt Cap1.8B
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
About
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Show more...
CEO
David H. Kirn
Employees
196
Country
United States
ISIN
US35104E1001
Listings
0 Comments
Share your thoughts
FAQ
What is 4D Molecular Therapeutics stock price today?▼
The current price of FDMT is $14.97 USD — it has increased by +1.84% in the past 24 hours. Watch 4D Molecular Therapeutics stock price performance more closely on the chart.
What is 4D Molecular Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange 4D Molecular Therapeutics stocks are traded under the ticker FDMT.
Is 4D Molecular Therapeutics stock price growing?▼
FDMT stock has risen by +2.04% compared to the previous week, the month change is a +45.62% rise, over the last year 4D Molecular Therapeutics has showed a +105.91% increase.
What is 4D Molecular Therapeutics market cap?▼
Today 4D Molecular Therapeutics has the market capitalization of 827.01M
When is the next 4D Molecular Therapeutics earnings date?▼
4D Molecular Therapeutics is going to release the next earnings report on November 11, 2026.
What were 4D Molecular Therapeutics earnings last quarter?▼
FDMT earnings for the last quarter are -1.04 USD per share, whereas the estimation was -1.02 USD resulting in a -2.3% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 4D Molecular Therapeutics revenue for the last year?▼
4D Molecular Therapeutics revenue for the last year amounts to 85.21M USD.
What is 4D Molecular Therapeutics net income for the last year?▼
FDMT net income for the last year is -140.11M USD.
How many employees does 4D Molecular Therapeutics have?▼
As of September 05, 2026, the company has 196 employees.
In which sector is 4D Molecular Therapeutics located?▼
4D Molecular Therapeutics operates in the Health & Wellness sector.
When did 4D Molecular Therapeutics complete a stock split?▼
4D Molecular Therapeutics has not had any recent stock splits.
Where is 4D Molecular Therapeutics headquartered?▼
4D Molecular Therapeutics is headquartered in EMERYVILLE, United States.